Skip to main content

Advertisement

Log in

BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ

  • Special Feature
  • Preoperative evaluation for intraductal spread of breast cancer through current imaging tests: their strengths and limitations
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

There has been dramatic progress in MRI technology during the past 20 years, and the rate of detection and diagnostic accuracy in regard to intraductal carcinoma and ductal carcinoma in situ (DCIS) have been increasing. First, we present MRI images of intraductal carcinomas and the terminology in the second edition of the BI-RADS-MRI to describe them. Next, we examined the data in our institution in regard to the following: (1) the DCIS detection rate, (2) the proportions of breast cancer and DCIS in MR-guided vacuum-assisted biopsies (VAB), (3) evaluation of the extent of intraductal carcinoma, and (4) diagnosis of extension of intraductal carcinoma into the nipple. MR images were acquired by performing a 1-min interval dynamic study with a 1.5-T MR scanner. The same radiologist evaluated the MRI in all of the cases. MR-guided VAB was performed by using a commercially available biopsy system. (1) The DCIS detection rate was 95% (148/156), and the DCIS lesions that MRI was unable to detect were low grade in 5 cases, intermediate grade in 2 cases, and high grade in 1 case. (2) The proportion of MR-guided VAB specimens that were breast cancer was 36% (71/200), and the proportion of breast cancers that were DCIS was 82% (58/71). (3) The proportion of margin-positive specimens in the 100 breasts in which breast-conserving surgery was performed was 11% (11/100), and the proportion in which MRI was the cause of the margin being positive was a mere 4% (4/100). (4) The positive predictive value of periductal enhancement and linear enhancement for a diagnosis of intraductal extension into the nipple was 83% (10/12) and 43% (3/7), respectively. Their negative predictive value was 100% (58/58). We concluded that MRI is a very useful examination for the diagnosis of intraductal carcinoma, and that it is important to become thoroughly familiar with the BI-RADS-MRI terminology and accurate interpretation methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Tozaki M. Diagnosis of breast cancer: MDCT versus MRI. Breast Cancer. 2008;15:205–11.

    Article  PubMed  Google Scholar 

  2. American College of Radiology. ACR practice guideline for the performance of contrast enhanced magnetic resonance imaging of the breast. 2011. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast.aspx. Accessed 17 Aug 2011

  3. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18:1307–18.

    Article  PubMed  CAS  Google Scholar 

  4. Tozaki M, Fukuma E. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol. 2009;193:840–9.

    Article  PubMed  Google Scholar 

  5. Schnitt SJ, Connolly JL, Khettry U, et al. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer. 1987;59:675–81.

    Article  PubMed  CAS  Google Scholar 

  6. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990;8:113–8.

    PubMed  CAS  Google Scholar 

  7. American College of Radiology. Breast imaging reporting and data system (BI-RADS), 4th ed. Reston: American College of Radiology, 2003.

  8. Liberman L, Morris EA, Dershaw DD, et al. Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol. 2003;181:519–25.

    PubMed  Google Scholar 

  9. Tozaki M, Fukuda K. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors. AJR Am J Roentgenol. 2006;187:330–7.

    Article  PubMed  Google Scholar 

  10. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol. 2002;179:171–8.

    PubMed  Google Scholar 

  11. Tozaki M, Igarashi T, Fukuda K. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement. AJR Am J Roentgenol. 2006;187:313–21.

    Article  PubMed  Google Scholar 

  12. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.

    Article  PubMed  Google Scholar 

  13. Tozaki M, Yamashiro N, Suzuki T, et al. MR-guided vacuum-assisted breast biopsy: is it an essential technique? Breast Cancer. 2009;16:121–5.

    Article  PubMed  Google Scholar 

  14. Tozaki M, Yamashiro N, Sakamoto M, et al. MR-guided vacuum-assisted breast biopsy: results in 100 Japanese women. Jpn J Radiol. 2010;28:527–33.

    Article  PubMed  Google Scholar 

  15. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563–71.

    Article  PubMed  Google Scholar 

  16. Sakamoto N, Fukuma E, Higa K, et al. Early results of an endoscopic nipple-sparing mastectomy for breast cancer. Ann Surg Oncol. 2009;16:3406–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsuhiro Tozaki.

About this article

Cite this article

Tozaki, M. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ. Breast Cancer 20, 13–20 (2013). https://doi.org/10.1007/s12282-011-0312-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-011-0312-3

Keywords

Navigation